7-64706942-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001282359.2(ZNF107):āc.845A>Gā(p.Glu282Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,612,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001282359.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF107 | NM_001282359.2 | c.845A>G | p.Glu282Gly | missense_variant | 4/4 | ENST00000620827.6 | NP_001269288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF107 | ENST00000620827.6 | c.845A>G | p.Glu282Gly | missense_variant | 4/4 | 4 | NM_001282359.2 | ENSP00000483720.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000684 AC: 17AN: 248552Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134746
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460650Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 726612
GnomAD4 genome AF: 0.000236 AC: 36AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.638A>G (p.E213G) alteration is located in exon 7 (coding exon 2) of the ZNF107 gene. This alteration results from a A to G substitution at nucleotide position 638, causing the glutamic acid (E) at amino acid position 213 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at